Cannapharmarx (CPMD) has released an update.
CannaPharmaRx, an emerging leader in advanced cannabis production, has announced an investor conference call for March 19, 2024, to discuss its progress and updates on operations, licensing, products, partnerships, and revenue forecasts. CEO Dean Medwid will lead the presentation, which interested parties can access via dial-in or a subsequent webcast replay. The company aims to excel in the cannabis market through cost-effective, high-quality production and strategic facility acquisitions.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.
